We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-6.3%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$563M
AUM Growth
-$77.2M
Cap. Flow
+$3.41M
Cap. Flow %
0.61%
Top 10 Hldgs %
62.51%
Holding
124
New
20
Increased
17
Reduced
10
Closed
12
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
GPGI icon
GPGI Inc
GPGI
+$11M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$10.8M
3
BC icon
Brunswick
BC
+$5.76M
4
TV icon
Televisa
TV
+$5.18M
5
DUOT icon
Duos Technologies
DUOT
+$4.54M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$32.8M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.66M
3
IHC
Independence Holding Company
IHC
+$3.1M
4
EPD icon
Enterprise Products Partners
EPD
+$2.77M
5
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 19.74%
2 Miscellaneous 15.57%
3 Industrials 15.14%
4 Financials 14.94%
5 Materials 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QUMU
51
DELISTED
Qumu Corp.
QUMU
$880K 0.16%
500,000
– –
2021 Q1
4 quarters
BILL icon
52
BILL Holdings
BILL
$4B
$872K 0.15%
3,845
+3,025
+369% +$631K
2021 Q4
1 quarter
CRNC icon
53
Cerence
CRNC
$415M
$855K 0.15%
+23,695
New +$1.17M
2022 Q1
0 quarters
TBCH icon
54
Turtle Beach Corp
TBCH
$290M
$843K 0.15%
+39,608
New +$829K
2022 Q1
0 quarters
ICCC icon
55
ImmuCell
ICCC
$95.9M
$686K 0.12%
71,073
+8,824
+14% +$76.1K
2021 Q2
3 quarters
ISPC icon
56
iSpecimen
ISPC
$2.59M
$666K 0.12%
82
-346
-81% -$1.35M
2021 Q2
3 quarters
ATIP
57
DELISTED
ATI Physical Therapy, Inc.
ATIP
$638K 0.11%
6,785
-4,818
-42% -$614K
2021 Q3
2 quarters
ARKOW icon
58
DELISTED
ARKO Corp Warrant
ARKOW
$633K 0.11%
333,333
– –
2020 Q4
5 quarters
COIN icon
59
Coinbase
COIN
$48.5B
$627K 0.11%
3,300
-2,299
-41% -$449K
2021 Q4
1 quarter
RTX icon
60
RTX Corp
RTX
$252B
$594K 0.11%
6,000
– –
2020 Q2
7 quarters
PYPL icon
61
PayPal
PYPL
$48.9B
$590K 0.1%
5,100
+100
+2% +$13.3K
2020 Q1
8 quarters
LBTYA icon
62
Liberty Global Class A
LBTYA
$2.74B
$586K 0.1%
22,989
– –
2019 Q4
9 quarters
SLGC
63
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$562K 0.1%
70,100
– –
2021 Q2
3 quarters
DOCN icon
64
DigitalOcean
DOCN
$12.9B
$543K 0.1%
+9,379
New +$548K
2022 Q1
0 quarters
BKTI icon
65
BK Technologies
BKTI
$251M
$508K 0.09%
39,880
– –
2021 Q2
3 quarters
PHR icon
66
Phreesia
PHR
$685M
$487K 0.09%
+18,470
New +$566K
2022 Q1
0 quarters
CELC icon
67
Celcuity
CELC
$2.95B
$468K 0.08%
50,000
– –
2021 Q1
4 quarters
YEXT icon
68
Yext
YEXT
$706M
$413K 0.07%
60,000
– –
2021 Q1
4 quarters
LHX icon
69
L3Harris
LHX
$44.8B
$398K 0.07%
1,600
– –
2019 Q4
9 quarters
RBLX icon
70
Roblox
RBLX
$36.5B
$365K 0.06%
7,901
+2,777
+54% +$168K
2021 Q4
1 quarter
YUMC icon
71
Yum China
YUMC
$15.1B
$324K 0.06%
+7,805
New +$368K
2022 Q1
0 quarters
WGS icon
72
GeneDx Holdings
WGS
$2.09B
$322K 0.06%
3,182
+152
+5% +$16.9K
2021 Q3
2 quarters
PETQ icon
73
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$310K 0.06%
+12,687
New +$267K
2022 Q1
0 quarters
INFI
74
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$285K 0.05%
250,000
– –
2019 Q4
9 quarters
CARR icon
75
Carrier Global
CARR
$45.3B
$275K 0.05%
6,000
– –
2020 Q2
7 quarters
1 2
3
4 5

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2022 Portfolio in Review

As of Q1 2022, Bleichroeder LP held 124 positions worth $563M, down 12% from $641M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP's Q1 2022 filing shows 20 new, 17 increased, 10 reduced and 12 closed positions. Its largest new stake was GPGI Inc: 1,776,008 shares worth $11.2M. The largest sale was Royalty Pharma, an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.

  • Bleichroeder LP's largest Q1 2022 buy was GPGI Inc: 1,776,008 shares worth $11.2M.
  • Bleichroeder LP added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2022, an estimated $10.8M increase.
  • Bleichroeder LP's biggest Q1 2022 reduction was Tricida, Inc. Common Stock, cutting an estimated $1.53M.
  • Bleichroeder LP fully exited Royalty Pharma in Q1 2022, selling an estimated $32.8M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $563M portfolio in Q1 2022.
  • Bleichroeder LP opened 20 new positions and closed 12 in Q1 2022.
  • Bleichroeder LP's portfolio value fell 12% quarter-over-quarter to $563M.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.